NASDAQ:ITOS

iTeos Therapeutics News Headlines

$18.59

+1.64 (+9.68%)

(As of 05/20/2022 12:00 AM ET)

Add

Compare

Today's Range: $16.66
▼
$18.68
50-Day Range: $16.92
▼
$37.00
52-Week Range: $16.35
▼
$52.43

Volume: 619,539 shs
Average Volume: 571,056 shs
Market Capitalization: $660.69 million

P/E Ratio: 2.38
Dividend Yield: N/A
Beta: 1.94

Get iTeos Therapeutics News Delivered to You Automatically

Media Mentions By Week

iTeos Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ITOS
News Sentiment
▼
1.08

0.30
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ITOS Articles
This Week
▼
6

1
▲
ITOS Articles
Average Week

iTeos Therapeutics (NASDAQ:ITOS) News Headlines Today

Source

Source	Headline
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Up 35.0% in April marketbeat.com - May 16 at 8:37 AM
	iTeos Therapeutics (NASDAQ:ITOS) Shares Gap Up to $18.30 americanbankingnews.com - May 19 at 5:14 AM
	iTeos Therapeutics (NASDAQ:ITOS) vs. Eiger BioPharmaceuticals (NASDAQ:EIGR) Critical Comparison americanbankingnews.com - May 17 at 2:40 AM
	Forecast: Analysts Think iTeos Therapeutics, Inc.'s (NASDAQ:ITOS) Business Prospects Have Improved Drastically finance.yahoo.com - May 16 at 10:37 AM
	iTeos Therapeutics (NASDAQ:ITOS) Stock Price Down 2.5% americanbankingnews.com - May 15 at 3:36 AM
	Blue Water Vaccines, Oscar Health top healthcare gainers, Inovio, iTeos lead losers' pack seekingalpha.com - May 13 at 10:45 PM
	Aaron I. Davis Sells 225,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock americanbankingnews.com - May 13 at 4:22 AM
	Aaron I. Davis Sells 338,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock americanbankingnews.com - May 13 at 4:22 AM
	ITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue Estimates finance.yahoo.com - May 13 at 12:15 AM
	iTeos Reports First Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - May 12 at 5:54 PM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) to Post Q3 2022 Earnings of $2.77 Per Share, SVB Leerink Forecasts americanbankingnews.com - May 12 at 2:50 AM
	Biotech Stocks Hammered On Roche's Unexpected Failure In Lung Cancer finance.yahoo.com - May 11 at 4:52 PM

	Recent 8.9% pullback isn't enough to hurt long-term iTeos Therapeutics (NASDAQ:ITOS) shareholders, they're still up 13% over 1 year finance.yahoo.com - May 11 at 11:51 AM
	Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others finance.yahoo.com - May 11 at 11:51 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Forecasted to Earn Q1 2022 Earnings of $0.96 Per Share americanbankingnews.com - May 11 at 1:48 AM
	Aaron I. Davis Sells 100,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock americanbankingnews.com - May 3 at 4:44 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Aaron I. Davis Sells 150,000 Shares americanbankingnews.com - May 3 at 4:13 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Aaron I. Davis Sells 100,000 Shares of Stock americanbankingnews.com - May 3 at 4:13 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Expected to Announce Quarterly Sales of $63.30 Million americanbankingnews.com - May 3 at 3:38 AM
	InnoSkel: Innoskel Appoints Dr Michel Detheux as Chairman finanznachrichten.de - April 12 at 5:33 AM
	Innoskel Appoints Dr Michel Detheux as Chairman finance.yahoo.com - April 12 at 5:33 AM
	iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022 finance.yahoo.com - April 8 at 6:54 PM
	Analysts Just Slashed Their iTeos Therapeutics, Inc. (NASDAQ:ITOS) EPS Numbers finance.yahoo.com - March 26 at 5:41 PM
	ITeos Therapeutics, Inc. (ITOS) Tops Q4 Earnings and Revenue Estimates finance.yahoo.com - March 23 at 11:54 PM
	iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update finance.yahoo.com - March 23 at 6:54 PM
	iTeos Therapeutics Inc.: iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer finanznachrichten.de - January 10 at 11:25 AM
	iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer finance.yahoo.com - January 10 at 11:25 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Major Shareholder Bioventures 2018 L.P. Mpm Sells 128,550 Shares insidertrades.com - January 6 at 6:19 PM
	First Week of July 15th Options Trading For iTeos Therapeutics nasdaq.com - January 4 at 12:30 PM
	iTeos Therapeutics Inc.: iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference finanznachrichten.de - January 3 at 6:02 PM
	Why iTeos Therapeutics Topped the Market Today finance.yahoo.com - January 3 at 6:02 PM
	ITeos Therapeutics Inc Insiders are Selling. Investors Should Take Notice finance.yahoo.com - December 29 at 2:35 PM
	ITeos Therapeutics Inc Shares Near 52-Week High - Market Mover nasdaq.com - December 26 at 8:44 AM
	Iteos Therapeutics Inc (ITOS) CEO Michel Detheux Sold $2 million of Shares finance.yahoo.com - December 23 at 10:33 AM
	iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021 finance.yahoo.com - December 9 at 6:14 PM

	Ona Therapeutics: ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors finanznachrichten.de - December 3 at 8:28 PM
	ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors ca.finance.yahoo.com - December 3 at 8:28 PM
	Notable Iteos Therapeutics Insider Trades $1.1M In Company Stock finance.yahoo.com - November 22 at 3:50 PM
	Why iTeos Therapeutics, Inc. (ITOS) Might be Well Poised for a Surge finance.yahoo.com - November 16 at 6:14 PM
	Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 53%: Here's is How to Trade finance.yahoo.com - November 16 at 1:14 PM
	iTeos Therapeutics Inc.: iTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates finanznachrichten.de - November 12 at 7:29 AM
	ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates finance.yahoo.com - November 11 at 12:02 AM
	iTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates finance.yahoo.com - November 10 at 7:02 PM
	Chief Executive Officer Of Iteos Therapeutics Sold $590K In Stock finance.yahoo.com - November 4 at 6:24 PM
	iTeos to Report Third Quarter 2021 Financial Results on November 10, 2021 finance.yahoo.com - November 3 at 9:47 AM
	We Think iTeos Therapeutics (NASDAQ:ITOS) Can Afford To Drive Business Growth nasdaq.com - October 18 at 11:14 AM
	We're Not Very Worried About iTeos Therapeutics' (NASDAQ:ITOS) Cash Burn Rate finance.yahoo.com - October 18 at 11:14 AM
	Chief Executive Officer Of Iteos Therapeutics Sold $None In Stock benzinga.com - September 29 at 2:27 AM
	Chief Executive Officer Of Iteos Therapeutics Sold $180K In Stock benzinga.com - September 29 at 2:27 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Could Be Less Than A Year Away From Profitability nasdaq.com - September 3 at 8:24 AM
	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Is About To Turn The Corner finance.yahoo.com - September 2 at 5:24 PM

Get iTeos Therapeutics News Delivered to You Automatically

This page was last updated on 5/22/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources